McAleer & Rushe lends support to bowel cancer research

McAleer& Rushe has announced that it has made a significant donation to Bowel Cancer UK to help fund the charity’s bowel cancer research grants programme.

There search focuses on three key themes: improving bowel cancer screening; the identification and surveillance of high-risk groups; and understanding bowel cancer in the under 50’s. 

Eamonn Laverty (Chief Executive of McAleer & Rushe), Deorah Alsina MBE (Bowel Cancer UK) & Seamus McAleer (Chair of McAleer & Rushe)

Deborah Alsina MBE, Chief Executive at Bowel Cancer UK, said:

“More than 42,000 people are diagnosed with bowel cancer each year in the UK and tragically over 16,000 people die every year.  We are determined to change that, but we can’t do it alone, which is why we are incredibly grateful to McAleer& Rushe for this wonderful support.”

“Donations like this enables us to pump prime research which will help us ensure in the future more people at high risk of the disease are identified and that more people have the opportunity to either have bowel cancer prevented or detected earlier.  Quite simply, McAleer & Rushe is helping us create a future where nobody dies of bowel cancer.”